Target intelligence / Profile preview

DMPK 3' UTR CUG repeat RNA (DMPK CUG repeat RNA)

Target
DMPK CUG repeat RNA
Molecular classification
RNA, Non-coding RNA element, Trinucleotide repeat RNA
01

Overview

The DMPK CUG repeat-containing RNA refers to the expanded trinucleotide CUG repeats in the 3'-untranslated region (3'-UTR) of the myotonic dystrophy protein kinase (DMPK) gene transcript, which is the primary pathogenic element in myotonic dystrophy type 1 (DM1), a multisystem neuromuscular disorder.[1][2][6] In DM1 patients, these repeats expand beyond 50-100 triplets (normal: 5-37), forming stable hairpin structures with length-dependent plasticity, including single asymmetrical hairpins or branched conformations, that cause nuclear retention of the mutant DMPK mRNA in discrete foci.[1][3] These RNA foci sequester RNA-binding proteins such as muscleblind-like (MBNL) family members, leading to misregulated alternative splicing of numerous transcripts and contributing to DM1 phenotypes like muscle weakness, myotonia, and cardiac issues.[2][4] The structured environment around the repeats, including a G6-clamp and GC-rich helices, isolates the CUG tract and maintains overall DMPK RNA folding despite expansion.[1] Therapeutically, this RNA is targeted by antisense oligonucleotides (AONs), siRNAs like siCAG, and gapmers, which disrupt hairpins, degrade the toxic RNA via RNase H, reduce foci, and alleviate splicing defects, with greater potency against longer expansions.[1][2][4] Ongoing research validates these approaches in cellular and mouse models of DM1.[2][5]

Other names
Expanded CUG repeats in DMPK transcriptsCUG^exp^ RNADMPK mutant RNADM1 RNA foci
02

Mechanism of action

RNase H-mediated degradation of toxic RNA; RNA interference (RNAi) knockdown of expanded CUG transcripts; Disruption of CUG repeat hairpin structures via base-pairing competition; Reduction of nuclear RNA foci and release of sequestered proteins like MBNL

03

Biological functions

Nuclear retention and foci formationSequestration of RNA-binding proteins (e.g., MBNL)Misregulation of alternative splicingRepeat-associated non-AUG (RAN) translation
04

Disease associations

Myotonic dystrophy type 1 (DM1)
05

Safety considerations

Potential off-target effects on wild-type DMPK allele or other CUG-containing transcriptsReduced efficacy against shorter, normal-length repeats compared to expanded repeats
06

Interacting drugs

Antisense oligonucleotides (AONs), including LNA AONs

2 more in the full profile.

Beyond the preview

Go deeper on DMPK 3' UTR CUG repeat RNA (DMPK CUG repeat RNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on DMPK 3' UTR CUG repeat RNA (DMPK CUG repeat RNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call